C191727Level 4

Regimen Used to Treat Castleman disease

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** Any regimen that can be used for the treatment of Castleman disease.

GET/api/v1/systems/nci_thesaurus/nodes/C191727

Official DownloadCC BY 4.0Source

Hierarchy Explorer

Hierarchy ExplorerChevron to expand - click title to open

C160033Etoposide Regimen

C160124Thalidomide Regimen

C191732Siltuximab Regimen

C191733Tocilizumab Regimen

C191913Liposomal Doxorubicin/Ganciclovir Regimen

C191916Liposomal Doxorubicin/Valganciclovir Regimen

C191917Ganciclovir/High-dose Zidovudine Regimen

C191918Valganciclovir/High-dose Zidovudine Regimen

C191919Ganciclovir/Vinblastine Regimen

C191920Valganciclovir/Vinblastine Regimen

C191924Etoposide/Ganciclovir Regimen

C191925Etoposide/Valganciclovir Regimen

C198020Rituximab/Vinblastine Regimen

C198529TCP Regimen

C204008Liposomal Doxorubicin/Rituximab Regimen

C204009Liposomal Doxorubicin/Prednisone/Rituximab Regimen

C205583Rituximab Followed by Prednisone

C205584Etoposide/Rituximab Regimen

Cross-system equivalences0

No cross-system equivalences mapped for this node.

Report a data issue